NextBio upgrades life Science platform to aid translational research

The curated genomic, molecular and clinical profiles from individual patients are added to the platform’s existing repository of data from animal and cell line models.

NextBio president and chief executive officer Saeid Akhtari said with NextBio Clinical, the company directly addresses the challenges of taking genomics into clinical research for the development of therapeutics and companion diagnostics.

"By providing patient-centric data and analysis, we facilitate biomarker-driven research that can accelerate the process of translational drug discovery," Akhtari added.

The platform combines terabyte-scale collections of private and public cross-platform omic data, experimental data from cell lines and other sources, and clinical data from individual patients and population studies.

The platform framework will remove confounding gene, disease and compound annotations, the company said.